by Robert Hayes Posted on April 23, 2024April 23, 2024 BUSINESS BRIEF: Wilmington’s Charles River Labs Achieves 100% Renewable Electricity Usage Globally Read More
by Robert Hayes Posted on April 16, 2024April 17, 2024 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Launches Alternative Methods Advancement Project To Reduce Reliance on Animal Testing Read More
by Robert Hayes Posted on April 5, 2024April 5, 2024 BUSINESS BRIEF: Wilmington’s Charles River & Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration Read More
by Robert Hayes Posted on January 29, 2024January 29, 2024 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Adds Reshema Kemps-Polanco To Board Of Directors Read More
by Robert Hayes Posted on December 3, 2023December 3, 2023 BUSINESS BRIEF: Wilmington’s Charles River & Genetic Cures for Kids Announce Gene Therapy Manufacturing Collaboration Read More
by Robert Hayes Posted on July 26, 2023July 26, 2023 OBITUARY: Kathleen A. Murray, D.V.M, 68 Read More
by Robert Hayes Posted on April 29, 2023April 29, 2023 Wilmington’s Charles River Labs Named A Top Ten Massachusetts Company For Gender Equity Among Executive Leadership Read More
by Robert Hayes Posted on February 17, 2023February 17, 2023 Wilmington’s Charles River Laboratories & Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration Read More
by Robert Hayes Posted on February 2, 2023February 3, 2023 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Acquires SAMDI Tech For $50 Million Read More
by Robert Hayes Posted on June 28, 2022June 28, 2022 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Announces Opening of U.K. Manufacturing Facility Read More
Wilmington Apple 
You must be logged in to post a comment.